Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Accumulated Expenses: 2009-2021

Historic Accumulated Expenses for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Dec 2021 value amounting to $7.2 million.

  • Avadel Pharmaceuticals' Accumulated Expenses fell 8.85% to $8.0 million in Q3 2022 from the same period last year, while for Sep 2022 it was $8.0 million, marking a year-over-year decrease of 8.85%. This contributed to the annual value of $7.2 million for FY2021, which is 10.00% up from last year.
  • According to the latest figures from FY2021, Avadel Pharmaceuticals' Accumulated Expenses is $7.2 million, which was up 10.00% from $6.5 million recorded in FY2020.
  • Avadel Pharmaceuticals' Accumulated Expenses' 5-year high stood at $50.9 million during FY2017, with a 5-year trough of $6.5 million in FY2020.
  • In the last 3 years, Avadel Pharmaceuticals' Accumulated Expenses had a median value of $7.2 million in 2021 and averaged $11.2 million.
  • As far as peak fluctuations go, Avadel Pharmaceuticals' Accumulated Expenses surged by 195.70% in 2017, and later slumped by 67.18% in 2020.
  • Avadel Pharmaceuticals' Accumulated Expenses (Yearly) stood at $50.9 million in 2017, then slumped by 57.40% to $21.7 million in 2018, then declined by 8.69% to $19.8 million in 2019, then plummeted by 67.18% to $6.5 million in 2020, then grew by 10.00% to $7.2 million in 2021.